Impact News +++ IDEXX: Gewinn pro Aktie verfehlt Ziel für Q4 2025 – Aktie gibt nach (Investing.com DE) +++ IDEXX Aktie -5,97%

Gewinn & Umsatz News zur REVVITY Aktie

>REVVITY Aktienkurs

88.9 EUR -3.2% (Tradegate)

Ask: 88.58 EUR / 340 Stück

Bid: 88.04 EUR / 340 Stück

Tagesumsatz: 295 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

REVVITY Aktie über LYNX handeln

Intraday

1 Jahr

>REVVITY Performance

1 Woche: -9,1%

1 Monat: +8,8%

3 Monate: +14,7%

6 Monate: +10,0%

1 Jahr: -26,0%

laufendes Jahr: +8,8%

>REVVITY Aktie

Name:

REVVITY INC. DL 1

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US7140461093 / 850943

Symbol/ Ticker:

PKN (Frankfurt) / RVTY (NYSE)

Kürzel:

FRA:PKN, ETR:PKN, PKN:GR, NYSE:RVTY

Index:

S&P500

Webseite:

https://www.revvity.com/

Profil:

Revvity Inc. is a prominent company in the healthc..
>Volltext..

Marktkapitalisierung:

10379.45 Mio. EUR

Unternehmenswert:

12476.66 Mio. EUR

Umsatz:

2374.06 Mio. EUR

EBITDA:

694.66 Mio. EUR

Nettogewinn:

201.24 Mio. EUR

Gewinn je Aktie:

1.69 EUR

Schulden:

2842.93 Mio. EUR

Liquide Mittel:

786.95 Mio. EUR

Operativer Cashflow:

483.3 Mio. EUR

Bargeldquote:

0.76

Umsatzwachstum:

-1.91%

Gewinnwachstum:

-25.45%

Dividende je Aktie:

0.24 EUR

Dividendenrendite:

0.26%

Dividendenschätzung:

0.26%

Div. Historie:

16.01.26 - 0.060234997€
17.10.25 - 0.06006€

>weitere anzeigen...

Insiderhandel:

Suchwörter:

REVVITY, PERKINELMER, PERKIN ELMER

Letzte Datenerhebung:

02.02.26

>REVVITY Kennzahlen

Aktien/ Unternehmen:

Aktien: 113.38 Mio. St.

Frei handelbar: 99.55%

Leerverk. Aktien: 6.11%

Rückkaufquote: 6.78%

Mitarbeiter: 11000

Umsatz/Mitarb.: 0.21 Mio. EUR

Analysten:

Analystenrating: Buy

Kursziel: 9.82%

Bewertung:

KGV: 52.54

KGV lG: 21.3

KUV: 4.42

KBV: 1.62

PEG-Ratio: -

EV/EBITDA: 17.96

Rentabilität:

Bruttomarge: 48.22%

Gewinnmarge: 8.26%

Operative Marge: 14.78%

Managementeffizenz:

Gesamtkaprendite: 1.87%

Eigenkaprendite: 3.04%

>REVVITY Anleihen

>REVVITY Peer Group

Gesundheit

>REVVITY Chart & Kurs - NYSE

>REVVITY Gewinn & Umsatz News

02.02.26 - 12:42	ROUNDUP: Revvity Guides FY26 Above Estimates (AFX)
	WASHINGTON (dpa-AFX) - While reporting financial results for the fourth quarter on Monday, biotechnology company Revvity, Inc. (RVTY) initiated its adjusted earnings and total revenue guidance for......

02.02.26 - 12:24	Revvity, Inc. Profit Climbs In Q4 (AFX)
	WASHINGTON (dpa-AFX) - Revvity, Inc. (RVTY) announced earnings for its fourth quarter that Increases, from last yearThe company's bottom line came in at $98.36 million, or $0.87 per share. This co......

13.01.26 - 18:24

US stocks today: Wall Street slip from record highs; earnings season opens on mixed note (Times of India)

Indian markets saw a cautious start as Wall Street edged lower amidst a mixed earnings season and expected inflation data. Major indices like the S&P 500 and Dow Jones experienced slight declines. While some companies disappointed, others like Revvity and Cardinal Health boosted outlooks, offering pockets of optimism. Inflation figures remained steady, keeping hopes for interest rate cuts alive....

19.11.25 - 15:06	Revvity Stock Outlook: Is Wall Street Bullish or Bearish? (Barchart)
	Um den gesamten Artikel unter newsbreak.com zu lesen, klicken Sie bitte auf die Überschrift...

27.10.25 - 11:36	Revvity, Inc. Q3 Profit Decreases, But Beats Estimates (AFX)
	WASHINGTON (dpa-AFX) - Revvity, Inc. (RVTY) released a profit for third quarter that Decreased from last year but beat the Street estimates.The company's earnings came in at $46.65 million, or $0.......

27.10.25 - 11:30	Revvity beats Q3 earnings expectations, raises full-year guidance (Investing.com)
	Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

16.10.25 - 08:48	Heres What to Expect From Revvitys Next Earnings Report (Barchart)
	Healthcare major Revvity is set to announce its third-quarter results in the upcoming weeks, and analysts expect a notable double-digit drop in earnings....

28.07.25 - 17:36	Revvity trims 2025 profit forecast as China policy changes hit diagnostics demand (Reuters EN)
	Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

28.07.25 - 13:12	Revvity Raises 2025 Revenue Guidance (AFX)
	WASHINGTON (dpa-AFX) - Revvity, Inc. (RVTY) said, for the full year 2025, it is raising revenue guidance to $2.84-$2.88 billion to reflect recent changes in foreign currency exchange rates and ass......

28.07.25 - 12:24	Revvity, Inc. Q2 Profit Beats Estimates (AFX)
	WASHINGTON (dpa-AFX) - Revvity, Inc. (RVTY) announced earnings for second quarter that beat the Street estimates.The company's bottom line totaled $53.95 million, or $0.46 per share. This compares......

15.07.25 - 15:30	Earnings Preview: What to Expect From Revvitys Report (Barchart)
	Revvity is all set to release its fiscal second-quarter earnings later this month, and analysts project a single-digit earnings decline....

28.04.25 - 19:30	Revvity joins peers Thermo Fisher, Danaher in tariff warning, maintains profit outlook (Reuters EN)
	Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

23.04.25 - 15:00	Revvity′s Quarterly Earnings Preview: What You Need to Know (Barchart)
	Revvity is gearing up to announce its first-quarter results later this month, and analysts expect a single-digit drop in earnings....

31.01.25 - 12:42	ROUNDUP: Revvity Guides FY25 Below Estimates (AFX)
	WASHINGTON (dpa-AFX) - While reporting financial results for the fourth quarter on Friday, biotechnology company Revvity, Inc. (RVTY) initiated its adjusted earnings and total revenue guidance for......

31.01.25 - 12:30	Revvity, Inc. Q4 Profit Increases, Beats Estimates (AFX)
	WASHINGTON (dpa-AFX) - Revvity, Inc. (RVTY) announced a profit for its fourth quarter that increased from last year and beat the Street estimates.The company's earnings totaled $94.65 million, or ......

15.01.25 - 15:18	Revvity′s Q4 2024 Earnings: What to Expect (Barchart)
	Revvity will release its fourth-quarter earnings later this month, and analysts anticipate a single-digit bottom-line growth....

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Es gibt ja nur zwei Sorten Menschen, die einen kultivierten Mann faszinieren können: Menschen, die alles wissen, und Menschen, die überhaupt nichts wissen. - Oscar Wilde

Partner: >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram